Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
PMN
STRONG SELLREMOVEProMIS Neurosciences, Inc. · Healthcare · Canada · $97M · Avg Vol: $190K/d
A micro-cap biotech focused on neurodegenerative diseases with high cash burn, binary clinical risks, and no commercial revenues.
COMPANY DESCRIPTION
ProMIS Neurosciences, Inc. is a biotechnology company focused on the discovery and development of precision therapeutics for neurodegenerative diseases, particularly Alzheimer's and Parkinson's. The company utilizes its proprietary discovery platform to identify toxic conformers of misfolded proteins as drug targets. Its competitive moat is its unique approach to targeting specific disease-causing protein structures, aiming for highly selective and effective treatments.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | — | 0 | 0 | 0 | 0 | — |
| EPS | — | -2.31 | -2.25 | 0.39 | -5.43 | — |
| Shares | — | 9.0M | 9.0M | 9.0M | 9.0M | 0.0% |
| Debt | 3.9M | 8.3M | 9.9M | 2.4M | 10.4M | 27.9% |
| Equity | — | -1.3M | 3.8M | 16.5M | -1.3M | 339.3% |
| Op CF | — | -17.0M | -10.8M | -27.2M | -28.1M | — |
| Inv CF | — | -1,981 | -1,349 | -693 | -702 | — |
| Fin CF | — | 6.5M | 17.7M | 27.9M | 20.9M | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of PMN are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| PMN | ProMIS Neurosciences, Inc.(you) | $97M | 15 | STRONG SELL |
| OBI.L | Ondine Biomedical Inc. | $101M | 20 | SELL |
| MSLE | Satellos Bioscience Inc. | $119M | 10 | STRONG SELL |
| ENGN | enGene Therapeutics Inc. | $114M | 8 | STRONG SELL |
| EDSA | Edesa Biotech, Inc. | $61M | 17 | STRONG SELL |
| MIST | Milestone Pharmaceuticals Inc. | $161M | 1 | STRONG SELL |
| HELP | Cybin D/B/A Helus Pharma | $245M | 6 | STRONG SELL |
| QNTM.CN | Quantum BioPharma Ltd. | $45M | 2 | STRONG SELL |
| NGEN | NervGen Pharma Corp. | $244M | 1 | STRONG SELL |
| TELI.CN | Telescope Innovations Corp. | $49M | 40 | HOLD |
Peer medians: ROE -42.2% · P/E 14.3x · Gross margin 35.6%